Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
about
New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis speciesInfluence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditisProtective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infectionCorrelation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.Efficacy of interleukin-1 beta against systemic Candida albicans infections in normal and immunosuppressed mice.Uveitis induction in the rabbit by muramyl dipeptidesSynergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.Prophylaxis of murine candidiasis via application of liposome-encapsulated amphotericin B and a muramyl dipeptide analog, alone and in combination.Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.The role of muramyl dipeptide in the therapy of established experimental bacterial infection.Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections.
P2860
Q28361150-AE54E238-7EA5-4F9D-898C-C5DF5F079F00Q30450496-2ACE4D61-C157-43D3-8C87-CB2853EBD030Q36341567-DA4209BD-DC28-4EF9-9411-24BBCCF93B29Q36433792-CA46BF65-E601-40DB-9C8B-25E33697CAC5Q37025433-67642212-269C-46C8-8BF6-6AE52288817AQ37028172-DB327A0A-7D39-40AF-9E11-A0B9684FC2DDQ37035564-8F717CB5-A894-461E-9A96-673F2A7098BDQ39850423-06E2BEBC-77E8-4D0E-8D69-B6F9B2C7675AQ40163385-7DF72D13-37E0-4A10-8303-C3D5751C789DQ40284852-30475DB8-995A-48C7-BC09-E199808C428BQ40600347-26CF84DC-BB7F-4435-9C39-36FBACBE7340Q41864167-A2B9CD78-07EA-4947-A4AA-E13F44924ED2Q42719351-5040E48A-1908-409D-8863-9D2C8F0BB4CC
P2860
Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Protective effect of muramyl d ...... a or Candida albicans in mice.
@ast
Protective effect of muramyl d ...... a or Candida albicans in mice.
@en
type
label
Protective effect of muramyl d ...... a or Candida albicans in mice.
@ast
Protective effect of muramyl d ...... a or Candida albicans in mice.
@en
prefLabel
Protective effect of muramyl d ...... a or Candida albicans in mice.
@ast
Protective effect of muramyl d ...... a or Candida albicans in mice.
@en
P2860
P1476
Protective effect of muramyl d ...... a or Candida albicans in mice.
@en
P2093
Fraser-Smith EB
Matthews TR
P2860
P304
P407
P577
1981-12-01T00:00:00Z